Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 16.
doi: 10.1007/s00266-025-04900-1. Online ahead of print.

Heavy Metals in Breast Implants and Implications for Breast Implant Illness: A Systematic Review of the Literature

Affiliations
Review

Heavy Metals in Breast Implants and Implications for Breast Implant Illness: A Systematic Review of the Literature

Jade E Smith et al. Aesthetic Plast Surg. .

Abstract

Purpose: Breast implant illness (BII) has raised concerns about breast implant safety, with some suggesting that heavy metals released from implants could contribute to systemic symptoms. This systematic review examines the presence of metal residues in breast implants and surrounding tissues, and their potential role in BII.

Methods: A systematic literature search following PRISMA guidelines was conducted using EMBASE, Web of Science, and PUBMED for studies published until January 2024. Inclusion criteria targeted material science and clinical research on metal residues in patients with breast implants. Data on metal concentrations, detection techniques, sample types, and clinical outcomes were extracted.

Results: Our search identified 304 titles, from which seven unique studies met inclusion criteria. Platinum, the most frequently detected metal, was detected in implant gel, capsular tissue, and systemic samples (blood, urine, and hair), in concentrations ranging from 0.001 to 125.27 μg/g. No consistent correlation was identified between metal levels and BII symptoms. Tin, aluminum, arsenic, and zinc were detected at low levels, below established toxicity thresholds, and often attributed to environmental exposure due to their presence in control groups. Inconsistencies in metal concentrations across studies were linked to variations in metal detection techniques and sample preparation.

Conclusion: We highlight the presence of metal residues, particularly platinum, in breast implants and adjacent tissue, but without a definitive link to BII. Current evidence does not support heavy metal toxicity as a primary justification for total capsulectomy in BII management. Further evidence-based clinical guidelines are needed to better inform management of BII.

Level of evidence iii: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Keywords: Breast implant illness; Heavy metals; Metal toxicity; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest: No conflicts of interest are associated with this publication. Human and Animals Rights: This article does not contain any studies with human participants or animals performed by any of the authors as it is a systematic review Informed Consent: For this type of study, informed consent is not required.

Similar articles

References

    1. The Aesthetic Society in collaboration with CosmetAssure. 2023 aesthetic plastic surgery statistics. The Aesthetic Society; 2023. https://cdn.theaestheticsociety.org/media/statistics/2023-TheAestheticSo... . Accessed 1 July 2024
    1. Bondurant S, Ernster V, Herdman R (eds.). Safety of silicone breast implants. Institute of Medicine (US) Committee on the Safety of Silicone Breast Implants. National Academies Press; 1999
    1. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Update on the safety of silicone gel-filled breast implants. FDA; 2011. https://www.fda.gov/files/medical%20devices/published/Update-on-the-Safe... . Accessed 1 July 2024
    1. U.S. Food and Drug Administration. Medical device reports for systemic symptoms in women with breast implants. FDA; 2025. https://www.fda.gov/medical-devices/breast-implants/medical-device-repor... . Accessed 7 May 2025
    1. Breastcancer.org. Breast implant removal (explant surgery): what to expect; 2025. https://www.breastcancer.org/treatment/surgery/breast-reconstruction/typ... . Accessed 7 May 2025

LinkOut - more resources